Novartis Gene Therapies, Inc., headquartered in East Hanover, NJ, appears in the available FY2024-FY2026 LCA dataset with 3 filing records, a limited sponsorship-filing pattern among U.S. employers tracked here. These are public LCA filings, not visa approvals, hires, or open roles, and the figures generally exclude equity, bonus, and benefits.
No elevated signal appears in the currently matched LCA and USCIS datasets. This is descriptive filing history, not immigration, legal, or employment advice.
Novartis Gene Therapies, Inc. has 3 H-1B LCA filing records in FY2024-FY2026.
The available filings do not provide enough complete wage observations for a peer comparison.
No matched PERM employer profile appears in the current public PERM dataset.
Novartis Gene Therapies, Inc. shows limited H-1B LCA filing activity in the available FY2024-FY2026 dataset, with 3 public LCA records. The largest filed role clusters include Quality Control Specialist. Major worksite filing activity appears in Durham, NC. These records are not final visa approvals, hires, or open roles.
The available LCA records do not provide enough complete wage observations for a median filed wage signal on this employer page.
No matched PERM employer profile appears for Novartis Gene Therapies, Inc. in the current FY2024-FY2025 dataset. That absence should not be read as an individual green-card outcome or legal conclusion.
Annual LCA filings across the available fiscal years.
Distribution is not available for this page because the source filings do not include enough complete salary observations.